000 01326 a2200325 4500
005 20250514165557.0
264 0 _c20040408
008 200404s 0 0 eng d
022 _a1175-3277
024 7 _a10.2165/00129784-200101010-00001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMetra, M
245 0 0 _aBeta-blockade in heart failure: selective versus nonselective agents.
_h[electronic resource]
260 _bAmerican journal of cardiovascular drugs : drugs, devices, and other interventions
_c2001
300 _a3-14 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdrenergic alpha-1 Receptor Antagonists
650 0 4 _aAdrenergic beta-1 Receptor Antagonists
650 0 4 _aAdrenergic beta-2 Receptor Antagonists
650 0 4 _aAdrenergic beta-Antagonists
_xpharmacology
650 0 4 _aClinical Trials as Topic
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aTreatment Outcome
700 1 _aNodari, S
700 1 _aDei Cas, L
773 0 _tAmerican journal of cardiovascular drugs : drugs, devices, and other interventions
_gvol. 1
_gno. 1
_gp. 3-14
856 4 0 _uhttps://doi.org/10.2165/00129784-200101010-00001
_zAvailable from publisher's website
999 _c14454488
_d14454488